Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Sun Pharmaceutical Industries Ltd
Acquired Company
Organon
Mumbai
Jersey CityBiotechnologyHealth CareBiotechnologyHealth CareMedicalDescription
Sun Pharmaceutical Industries is raising approximately $1.04 billion through a local debt sale to fund a bridge loan for acquiring Organon & Co. The company closed a nearly $12 billion bridge loan earlier this year for this acquisition. This financing move comes amidst rising global borrowing costs and aims to secure more stable funding.
Fundz sees it the moment Sun Pharmaceutical Industries Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Organon?
Organon was acquired by Sun Pharmaceutical Industries Ltd, based in Mumbai. The deal was reported on September 29, 2026. Sun Pharmaceutical Industries Ltd. is a multinational pharmaceutical company headquartered in Mumbai, India. Sun Pharmaceutical Industries Ltd is privately held and operates in Biotechnology.
When did Sun Pharmaceutical Industries Ltd acquire Organon?
Sun Pharmaceutical Industries Ltd's acquisition of Organon was reported on September 29, 2026. Sun Pharmaceutical Industries is raising approximately $1.04 billion through a local debt sale to fund a bridge loan for acquiring Organon & Co. The company closed a nearly $12 billion bridge loan earlier this year for this acquisition. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Organon do?
Organon is a global healthcare company formed through a spin-off from Merck, (NYSE: MRK) known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. It is publicly traded (OGN), operating in Biotechnology, and is based in Jersey City.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.